|
|
||||||||||||||
|
|
|||||||||||||||
a INSERM Unité
45, Hôpital E Herriot, 69437 Lyon Cedex 03, France, b Ecole
Pratique des Hautes Etudes, c Laboratoire d'Anatomie Pathologique
Correspondence to: Dr D Pansu, Ecole Pratique des Hautes Etudes, INSERM U45, Pavillon Hbis Hôpital Edouard Herriot, 69437 Lyon Cedex 03, France.
Accepted for publication 21 July 1999
BACKGROUND
Sorbin, a
153 amino acid peptide isolated from porcine intestine, was localised
by immunohistochemistry in endocrine cells of the intestinal mucosa and
pancreas and in the enteric nervous system in the pig.
AIMS
To identify
sorbin cells in normal human digestive tissues and to explore the
expression of sorbin in 37 digestive endocrine tumours: 14 intestinal
carcinoid tumours and 23 endocrine pancreatic tumours including six insulinomas.
METHODS
Two
polyclonal antibodies against the C-terminal and the N-terminal
sequences of porcine sorbin raised in rabbit were used to evaluate
sorbin expression by immunohistochemistry.
RESULTS
In the human
digestive tract, sorbin, characterised by both C-terminal and
N-terminal immunoreactivity, was found in enterochromaffin cells of the
gastric and intestinal epithelium from the pyloric junction to the
descending colon. C-Terminal sorbin immunoreactivity alone was found in
plexii from the enteric nervous system and in some insulin-containing
cells of normal pancreas. C-Terminal and N-terminal antibodies
disclosed sorbin in five of 14 intestinal carcinoid tumours; C-terminal
antibody alone disclosed a C-terminal sorbin peptide in two of six
insulinomas and three of 17 endocrine pancreatic tumours. The presence
of sorbin was not associated with a specific clinical syndrome.
CONCLUSIONS
Sorbin is
present in the digestive tract in several forms. It is expressed in
some intestinal and pancreatic endocrine tumours.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |